High incidence of cancer in anti-small ubiquitin-like modifier activating enzyme antibody-positive dermatomyositis

Rheumatology (United Kingdom)

Volumn 54, Issue 9, 2015, Pages 1745-1747

  Muro, Yoshinao ^a   Sugiura, Kazumitsu ^a   Nara, Mizuho ^b   Sakamoto, Izumi ^c   Suzuki, Noriyuki ^d   Akiyama, Masashi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Nagoya Memorial Hospital   (Japan)

^d TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ANTIBODY; SMALL UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME; UBIQUITIN; UNCLASSIFIED DRUG;

BLOOD SAMPLING; CANCER INCIDENCE; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DERMATOMYOSITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUNGARY; IMMUNOPRECIPITATION; INFORMED CONSENT; INTERSTITIAL LUNG DISEASE; ITALY; JAPAN; LETTER; MOLECULAR CLONING; PRIORITY JOURNAL; QUANTITATIVE ASSAY; THORAX RADIOGRAPHY; UNIVERSITY HOSPITAL; WESTERN BLOTTING;

EID: 84983200493     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kev247     Document Type: Letter

References (8)

1. Tansley SL, Betteridge ZE, McHugh NJ. The diagnostic utility of autoantibodies in adult and juvenile myositis. Curr Opin Rheumatol 2013;25:772-7.
2. Betteridge Z, Gunawardena H, North J, McHugh N. Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis. Arthritis Rheum 2007;56:3132-7.
3. Betteridge ZE, Gunawardena H, Chinoy H et al. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target in UK Caucasian adult-onset myositis. Ann Rheum Dis 2009;68:1621-5.
4. Tarricone E, Ghirardello A, Rampudda M et al. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. J Immunol Methods 2012;384:128-34.
5. Fujimoto M, Matsushita T, Hamaguchi Y et al. Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort. Ann Rheum Dis 2013;72:151-3.
6. Bodoki L, Nagy-Vincze M, Griger Z et al. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort. Autoimmun Rev 2014;13:1211-9.
7. Muro Y, Sugiura K, Akiyama M. Low prevalence of antismall ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients. Autoimmunity 2013;46:279-84.
8. Muro Y, Sugiura K, Akiyama M. A new ELISA for dermatomyositis autoantibodies: rapid introduction of autoantigen cDNA to recombinant assays for autoantibody measurement. Clin Dev Immunol 2013;2013:856815.